- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02980718
Does Olfactory Training Improve Olfaction in a Population With Normal Sense of Smell?
Does Olfactory Training Improve Olfaction in a Population With Normosmia and How is Their Self Assessment of Sense of Smell?
Awareness of the sense of smell in the western population has been low. Most people do not think about the consequences of absence of smell (anosmia). Reduction in sense of smell (hyposmia) can influence everyday life. In situations of stress anosmia can be life threatening for example when there is a fire. Cooks may lose their job. Not being able to enjoy food and drink interferes with quality of life. The causes of olfactory dysfunction (OD) vary. Most often OD is associated with upper respiratory tract infections, disease of the nose and sinuses or head injuries. OD may be congenital, age related or associated with neurological disorders. Hyposmia occurs in up to 85% of cases of Parkinson's and may be the first symptom of both Parkinson's and Alzheimer's disease several years before the mental changes occur.
Knowledge and focus on OD has until recently been low among most physicians and treatment options have often not been available. Different approaches to improve OD have been tried with variable effect depending on the cause of OD. There are studies on corticosteroids, zinc gluconate and vitamin A. In recent years, olfactory training has been launched as a promising treatment option. Most studies with olfactory training are done with patients with OD. A recently published review describes 10 studies with olfactory training among 639 patients and concludes that daily stimulation with odorants (odor concentrate) over a limited period time is a promising treatment. The suggested duration of olfactory training varies from 3 to 14 months. Different intensities of olfactory training were compared in patients with post-viral OD. Olfaction was more improved by the high concentration of odorant than by the low concentration.
A small number of studies have shown that the olfactory nerve to some extent can be trained in persons with normal sense of smell, but we need more experience and structured studies to be able to conclude with greater certainty about the effect of olfactory training in this population.
This study examines whether intensive olfactory training improves the sense of smell more than ordinary olfactory training in subjects with normal olfaction (normosmia) and examines self-evaluation of olfactory function.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Trondheim, Norway
- St Olavs Hospital, Klinikk ØNH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- TDI score > 30.5 measured by Sniffin'Sticks
Exclusion Criteria:
- Not able to follow the olfactory training or follow-up (language, practical implementation, mental condition)
- Disease affecting olfaction (sinusitis, pronounced allergies, recent nasal surgery, Alzheimer's, Parkinson, MS, COPD)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: intensive olfactory training
90 participants will undergo intensive olfactory training.
They will sniff on four selected odors (10 seconds on each odor bottle in a total of 4 minutes) every morning and evening for 3 months and they will be instructed in the principles of the logbook for olfactory training.
|
|
|
Experimental: ordinary olfactory training
90 participants will undergo ordinary olfactory training.
They will sniff on four selected odors (10 seconds on each odor bottle in a total of 40 seconds) every morning and evening for 3 months and they will be instructed in the principles of the logbook for olfactory training.
|
|
|
No Intervention: controls
20 participants represent a control group with no olfactory training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
olfaction assessed by TDI-score according to extended Sniffin'Sticks
Time Frame: 4 months (immediately after completion of the training period)
|
4 months (immediately after completion of the training period)
|
|
olfaction self-evaluated and reported in a questionnaire
Time Frame: 4 months (immediately after completion of the training period)
|
4 months (immediately after completion of the training period)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
olfaction assessed byTDI-score according to extended Sniffin'Sticks
Time Frame: 1 year (6-7 months after completion of the training period)
|
1 year (6-7 months after completion of the training period)
|
|
olfaction self-evaluated and reported in a questionnaire
Time Frame: 1 year (6-7 months after completion of the training period)
|
1 year (6-7 months after completion of the training period)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Ståle Nordgård, md prof, Norwegian University of Science and Technology
- Study Director: Marit Fagerli, md, St Olavs Hospital, Klinikk for Øre Nese Hals
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2016/837
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on People With Normal Sense of Smell
-
Bournemouth UniversityCompletedFrailty | Older People | Sense of ControlUnited Kingdom
-
University Medical Center GoettingenWithdrawnUtilization of Nursing, Medical and Therapeutical Care of People Living at Home With Care Needs
-
Universidad de ZaragozaIngesan-OHLACompletedPeople 60 Years of Age or Over 55 Years of Age With a Diagnosed Pathology and Preferably With a Recognized Physical and/or Cognitive DependencySpain
-
LG Life SciencesUnknownNormal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar RegionKorea, Republic of
-
Hospital Alemão Oswaldo CruzUniversity College, London; Ministry of Health, BrazilRecruitingCaregiver Burden of People With DementiaBrazil
-
Taipei Medical UniversityNational Science and Technology CouncilCompletedQuality of Life | Caregivers of People With DementiaTaiwan
-
USWM, LLC (dba US WorldMeds)National Institute on Drug Abuse (NIDA)CompletedNormal Healthy Volunteers Will be Treated With Lofexidine to Understand the Absolute Bioavailability and Mass Balance Recovery of the ProductUnited States
-
University of RochesterNational Institute on Aging (NIA); University of North Carolina, CharlotteCompletedCaregivers of People With DementiaUnited States
-
Rempex Pharmaceuticals (a wholly owned subsidiary...CompletedSubjects With Varying Degrees of Renal Insufficiency and | Subjects With Normal Renal FunctionUnited States
-
University of LeipzigGerman Center for Neurodegenerative Diseases (DZNE)CompletedCaregivers of People With DementiaGermany
Clinical Trials on intensive olfactory training
-
Peking University Third HospitalNot yet recruiting
-
University of Alabama at BirminghamRecruitingHIV (Human Immunodeficiency Virus)United States
-
University College, LondonCompleted
-
Johns Hopkins UniversityNorth American Skull Base SocietyCompletedAnosmia | Skull Base NeoplasmsUnited States
-
Anhui Medical UniversityNot yet recruitingParkinson Disease | Olfactory Disorder | Olfactory TrainingChina
-
University of OsloCompletedTaste Dysfunction | Smell Dysfunction | Trigeminal Dysfunction | Salivary DysfunctionNorway
-
Peking University Third HospitalRecruitingOlfactory ImpairmentChina
-
Jeffrey MotterAlzheimer's AssociationRecruiting
-
Karolinska InstitutetRegion SkaneCompleted